NCT03724890 2025-04-10
Study of Avelumab-M3814 Combinations
EMD Serono
Phase 1 Completed
EMD Serono
Baptist Health South Florida
University of Kentucky
National Institutes of Health Clinical Center (CC)
Abramson Cancer Center at Penn Medicine
University of Colorado, Denver
Icahn School of Medicine at Mount Sinai
University of Pittsburgh